Trial Outcomes & Findings for Combination of Peripheral Nerve Block and DepoDur in Total Knee Joint Replacement (NCT NCT00895531)

NCT ID: NCT00895531

Last Updated: 2017-07-27

Results Overview

Pain as reported on a verbal rating scale ( VRS) (0-10, 0 = no pain, 10 = worse pain imaginable).

Recruitment status

TERMINATED

Study phase

PHASE4

Target enrollment

75 participants

Primary outcome timeframe

48 hours

Results posted on

2017-07-27

Participant Flow

Participant milestones

Participant milestones
Measure
Peripheral Nerve Group
Depodur Group
Overall Study
STARTED
38
37
Overall Study
COMPLETED
38
37
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Peripheral Nerve Group
n=38 Participants
Depodur Group
n=37 Participants
Total
n=75 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=38 Participants
0 Participants
n=37 Participants
0 Participants
n=75 Participants
Age, Categorical
Between 18 and 65 years
38 Participants
n=38 Participants
37 Participants
n=37 Participants
75 Participants
n=75 Participants
Age, Categorical
>=65 years
0 Participants
n=38 Participants
0 Participants
n=37 Participants
0 Participants
n=75 Participants
Sex: Female, Male
Female
6 Participants
n=38 Participants
9 Participants
n=37 Participants
15 Participants
n=75 Participants
Sex: Female, Male
Male
32 Participants
n=38 Participants
28 Participants
n=37 Participants
60 Participants
n=75 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.

PRIMARY outcome

Timeframe: 48 hours

Pain as reported on a verbal rating scale ( VRS) (0-10, 0 = no pain, 10 = worse pain imaginable).

Outcome measures

Outcome measures
Measure
Peripheral Nerve Group
n=38 Participants
Depodur Group
n=37 Participants
Postoperative Pain
5 units on a scale
Standard Deviation 3
6 units on a scale
Standard Deviation 2

Adverse Events

Peripheral Nerve Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Depodur Group

Serious events: 1 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Peripheral Nerve Group
n=38 participants at risk
Depodur Group
n=37 participants at risk
Respiratory, thoracic and mediastinal disorders
Respiratory depression
0.00%
0/38
2.7%
1/37 • Number of events 1

Other adverse events

Adverse event data not reported

Additional Information

Nancy Alsip

University Louisville

Phone: 502-852-2905

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place